Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial

Efficacy and safety of berberine for dyslipidemia: study protocol for a randomized double-blind placebo-controlled trial

Abstract Background Dyslipidemia is a major risk factor for atherosclerotic cardiovascular disease and a leading cause of death worldwide. The clinical utility of commonly used lipid-lowering drugs such as statins and fibrates is sometimes limited by the occurrence of various adverse reactions. Rece...

Full description

Bibliographic Details
Main Authors: Ying Zhao, Yuan-Yuan Yang, Bao-Lin Yang, Ya-Wei Du, Da-Wei Ren, Hong-Mei Zhou, Jing Wang, Hui-Min Yang, Yao-Xian Wang, Ying-Ying Zhang, Sheng-Xian Wu
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Trials
Subjects:
Berberine
Dyslipidemia
Chinese herb
Randomized controlled trial
Online Access:https://doi.org/10.1186/s13063-021-05028-8

Similar Items

Similar Items